Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)A First in hUman Study for Resistant Epilepsy With the Vagus Nerve stimulatiOn Device by syneRgia medicAl
Not Applicable
Active, not recruiting
- Conditions
- Drug Resistant Epilepsy
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Synergia Medical
- Target Recruit Count
- 10
- Registration Number
- NCT06340802
- Locations
- 🇧🇪
Cliniques Universitaires St.-Luc, Brussels, Belgium
🇧🇪UZ GENT (Universitair Ziekenhuis Gent), Gent, Belgium
🇩🇪Universitätsklinikum Freiburg, Freiburg, Germany
News
Synergia Medical's NAO.VNS Device Shows Promising Results in First-in-Human Study for Drug-Resistant Epilepsy
Synergia Medical's NAO.VNS device met the primary safety endpoint in its first-in-human clinical study, with no serious adverse events reported over three months.
Synergia Medical's NAO.VNS System Successfully Implanted in First-in-Human Epilepsy Study
Synergia Medical successfully implanted its NAO.VNS system in two patients with drug-resistant epilepsy as part of the AURORA study.